nodes	percent_of_prediction	percent_of_DWPC	metapath
Formoterol—CYP2C9—Leflunomide—systemic scleroderma	0.092	0.433	CbGbCtD
Formoterol—CYP2D6—Captopril—systemic scleroderma	0.066	0.31	CbGbCtD
Formoterol—CYP2C19—Prednisone—systemic scleroderma	0.0547	0.257	CbGbCtD
Formoterol—CYP2C9—cardial valve—systemic scleroderma	0.0016	0.736	CbGeAlD
Formoterol—Chest pain—Lisinopril—systemic scleroderma	0.000627	0.000799	CcSEcCtD
Formoterol—Arthralgia—Lisinopril—systemic scleroderma	0.000627	0.000799	CcSEcCtD
Formoterol—Myalgia—Lisinopril—systemic scleroderma	0.000627	0.000799	CcSEcCtD
Formoterol—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000627	0.000799	CcSEcCtD
Formoterol—Anxiety—Lisinopril—systemic scleroderma	0.000625	0.000796	CcSEcCtD
Formoterol—Back pain—Mycophenolate mofetil—systemic scleroderma	0.000625	0.000796	CcSEcCtD
Formoterol—Dyspnoea—Leflunomide—systemic scleroderma	0.000624	0.000795	CcSEcCtD
Formoterol—Hypotension—Mycophenolic acid—systemic scleroderma	0.000624	0.000795	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000623	0.000794	CcSEcCtD
Formoterol—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000621	0.000791	CcSEcCtD
Formoterol—Discomfort—Lisinopril—systemic scleroderma	0.00062	0.00079	CcSEcCtD
Formoterol—Dyspepsia—Leflunomide—systemic scleroderma	0.000616	0.000785	CcSEcCtD
Formoterol—Vomiting—Mometasone—systemic scleroderma	0.000615	0.000783	CcSEcCtD
Formoterol—Dry mouth—Lisinopril—systemic scleroderma	0.000614	0.000782	CcSEcCtD
Formoterol—Feeling abnormal—Azathioprine—systemic scleroderma	0.000611	0.000778	CcSEcCtD
Formoterol—Rash—Mometasone—systemic scleroderma	0.00061	0.000777	CcSEcCtD
Formoterol—Asthenia—Captopril—systemic scleroderma	0.000609	0.000776	CcSEcCtD
Formoterol—Dermatitis—Mometasone—systemic scleroderma	0.000609	0.000776	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000608	0.000775	CcSEcCtD
Formoterol—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000606	0.000772	CcSEcCtD
Formoterol—Headache—Mometasone—systemic scleroderma	0.000606	0.000772	CcSEcCtD
Formoterol—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000605	0.000771	CcSEcCtD
Formoterol—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000604	0.00077	CcSEcCtD
Formoterol—Insomnia—Mycophenolic acid—systemic scleroderma	0.000604	0.000769	CcSEcCtD
Formoterol—Fatigue—Leflunomide—systemic scleroderma	0.000603	0.000769	CcSEcCtD
Formoterol—Oedema—Lisinopril—systemic scleroderma	0.000601	0.000766	CcSEcCtD
Formoterol—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000601	0.000766	CcSEcCtD
Formoterol—Pruritus—Captopril—systemic scleroderma	0.000601	0.000765	CcSEcCtD
Formoterol—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000599	0.000763	CcSEcCtD
Formoterol—Pain—Leflunomide—systemic scleroderma	0.000599	0.000762	CcSEcCtD
Formoterol—Constipation—Leflunomide—systemic scleroderma	0.000599	0.000762	CcSEcCtD
Formoterol—Infection—Lisinopril—systemic scleroderma	0.000598	0.000761	CcSEcCtD
Formoterol—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000595	0.000758	CcSEcCtD
Formoterol—Somnolence—Mycophenolic acid—systemic scleroderma	0.000594	0.000756	CcSEcCtD
Formoterol—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000593	0.000756	CcSEcCtD
Formoterol—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00059	0.000752	CcSEcCtD
Formoterol—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000588	0.000749	CcSEcCtD
Formoterol—Tachycardia—Lisinopril—systemic scleroderma	0.000587	0.000748	CcSEcCtD
Formoterol—Body temperature increased—Azathioprine—systemic scleroderma	0.000586	0.000746	CcSEcCtD
Formoterol—Abdominal pain—Azathioprine—systemic scleroderma	0.000586	0.000746	CcSEcCtD
Formoterol—Skin disorder—Lisinopril—systemic scleroderma	0.000584	0.000744	CcSEcCtD
Formoterol—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000582	0.000742	CcSEcCtD
Formoterol—Diarrhoea—Captopril—systemic scleroderma	0.000581	0.00074	CcSEcCtD
Formoterol—Feeling abnormal—Leflunomide—systemic scleroderma	0.000577	0.000735	CcSEcCtD
Formoterol—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000577	0.000734	CcSEcCtD
Formoterol—Fatigue—Mycophenolic acid—systemic scleroderma	0.000576	0.000733	CcSEcCtD
Formoterol—Nausea—Mometasone—systemic scleroderma	0.000574	0.000732	CcSEcCtD
Formoterol—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000572	0.000729	CcSEcCtD
Formoterol—Pain—Mycophenolic acid—systemic scleroderma	0.000571	0.000727	CcSEcCtD
Formoterol—Constipation—Mycophenolic acid—systemic scleroderma	0.000571	0.000727	CcSEcCtD
Formoterol—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000571	0.000727	CcSEcCtD
Formoterol—Hyperglycaemia—Prednisone—systemic scleroderma	0.000567	0.000722	CcSEcCtD
Formoterol—Cough—Mycophenolate mofetil—systemic scleroderma	0.000563	0.000718	CcSEcCtD
Formoterol—Hypotension—Lisinopril—systemic scleroderma	0.000562	0.000716	CcSEcCtD
Formoterol—Dizziness—Captopril—systemic scleroderma	0.000562	0.000715	CcSEcCtD
Formoterol—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000557	0.00071	CcSEcCtD
Formoterol—Urticaria—Leflunomide—systemic scleroderma	0.000556	0.000708	CcSEcCtD
Formoterol—Abdominal pain—Leflunomide—systemic scleroderma	0.000553	0.000705	CcSEcCtD
Formoterol—Body temperature increased—Leflunomide—systemic scleroderma	0.000553	0.000705	CcSEcCtD
Formoterol—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000552	0.000703	CcSEcCtD
Formoterol—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00055	0.000701	CcSEcCtD
Formoterol—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.00055	0.0007	CcSEcCtD
Formoterol—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.00055	0.0007	CcSEcCtD
Formoterol—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.00055	0.0007	CcSEcCtD
Formoterol—Myocardial infarction—Prednisone—systemic scleroderma	0.000549	0.000699	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000548	0.000698	CcSEcCtD
Formoterol—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000548	0.000698	CcSEcCtD
Formoterol—Hypersensitivity—Azathioprine—systemic scleroderma	0.000546	0.000696	CcSEcCtD
Formoterol—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000546	0.000696	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000546	0.000695	CcSEcCtD
Formoterol—Insomnia—Lisinopril—systemic scleroderma	0.000544	0.000693	CcSEcCtD
Formoterol—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000543	0.000692	CcSEcCtD
Formoterol—Vomiting—Captopril—systemic scleroderma	0.00054	0.000688	CcSEcCtD
Formoterol—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000538	0.000685	CcSEcCtD
Formoterol—Dyspnoea—Lisinopril—systemic scleroderma	0.000536	0.000683	CcSEcCtD
Formoterol—Rash—Captopril—systemic scleroderma	0.000536	0.000682	CcSEcCtD
Formoterol—Dermatitis—Captopril—systemic scleroderma	0.000535	0.000681	CcSEcCtD
Formoterol—Somnolence—Lisinopril—systemic scleroderma	0.000535	0.000681	CcSEcCtD
Formoterol—Headache—Captopril—systemic scleroderma	0.000532	0.000678	CcSEcCtD
Formoterol—Dyspepsia—Lisinopril—systemic scleroderma	0.000529	0.000674	CcSEcCtD
Formoterol—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000528	0.000672	CcSEcCtD
Formoterol—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000528	0.000672	CcSEcCtD
Formoterol—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000527	0.000671	CcSEcCtD
Formoterol—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000527	0.000671	CcSEcCtD
Formoterol—Asthma—Methotrexate—systemic scleroderma	0.000525	0.000669	CcSEcCtD
Formoterol—Infection—Mycophenolate mofetil—systemic scleroderma	0.000524	0.000667	CcSEcCtD
Formoterol—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000519	0.000661	CcSEcCtD
Formoterol—Fatigue—Lisinopril—systemic scleroderma	0.000519	0.000661	CcSEcCtD
Formoterol—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000517	0.000658	CcSEcCtD
Formoterol—Hypersensitivity—Leflunomide—systemic scleroderma	0.000516	0.000657	CcSEcCtD
Formoterol—Constipation—Lisinopril—systemic scleroderma	0.000514	0.000655	CcSEcCtD
Formoterol—Pain—Lisinopril—systemic scleroderma	0.000514	0.000655	CcSEcCtD
Formoterol—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000514	0.000655	CcSEcCtD
Formoterol—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000512	0.000652	CcSEcCtD
Formoterol—Diarrhoea—Azathioprine—systemic scleroderma	0.000507	0.000646	CcSEcCtD
Formoterol—Nausea—Captopril—systemic scleroderma	0.000504	0.000643	CcSEcCtD
Formoterol—Asthenia—Leflunomide—systemic scleroderma	0.000502	0.00064	CcSEcCtD
Formoterol—Feeling abnormal—Lisinopril—systemic scleroderma	0.000496	0.000631	CcSEcCtD
Formoterol—Pruritus—Leflunomide—systemic scleroderma	0.000495	0.000631	CcSEcCtD
Formoterol—Connective tissue disorder—Prednisone—systemic scleroderma	0.000494	0.000629	CcSEcCtD
Formoterol—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000492	0.000627	CcSEcCtD
Formoterol—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000492	0.000626	CcSEcCtD
Formoterol—Dizziness—Azathioprine—systemic scleroderma	0.00049	0.000624	CcSEcCtD
Formoterol—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000488	0.000621	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00048	0.000612	CcSEcCtD
Formoterol—Asthenia—Mycophenolic acid—systemic scleroderma	0.000479	0.00061	CcSEcCtD
Formoterol—Diarrhoea—Leflunomide—systemic scleroderma	0.000479	0.00061	CcSEcCtD
Formoterol—Urticaria—Lisinopril—systemic scleroderma	0.000478	0.000609	CcSEcCtD
Formoterol—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000477	0.000607	CcSEcCtD
Formoterol—Abdominal pain—Lisinopril—systemic scleroderma	0.000475	0.000606	CcSEcCtD
Formoterol—Body temperature increased—Lisinopril—systemic scleroderma	0.000475	0.000606	CcSEcCtD
Formoterol—Pruritus—Mycophenolic acid—systemic scleroderma	0.000472	0.000602	CcSEcCtD
Formoterol—Vomiting—Azathioprine—systemic scleroderma	0.000471	0.0006	CcSEcCtD
Formoterol—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00047	0.000598	CcSEcCtD
Formoterol—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000468	0.000597	CcSEcCtD
Formoterol—Rash—Azathioprine—systemic scleroderma	0.000467	0.000595	CcSEcCtD
Formoterol—Dermatitis—Azathioprine—systemic scleroderma	0.000467	0.000595	CcSEcCtD
Formoterol—Headache—Azathioprine—systemic scleroderma	0.000464	0.000591	CcSEcCtD
Formoterol—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000464	0.000591	CcSEcCtD
Formoterol—Dizziness—Leflunomide—systemic scleroderma	0.000463	0.00059	CcSEcCtD
Formoterol—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000457	0.000582	CcSEcCtD
Formoterol—Conjunctivitis—Methotrexate—systemic scleroderma	0.000455	0.00058	CcSEcCtD
Formoterol—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000455	0.00058	CcSEcCtD
Formoterol—Immune system disorder—Prednisone—systemic scleroderma	0.000454	0.000578	CcSEcCtD
Formoterol—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000451	0.000574	CcSEcCtD
Formoterol—Pain—Mycophenolate mofetil—systemic scleroderma	0.000451	0.000574	CcSEcCtD
Formoterol—Arrhythmia—Prednisone—systemic scleroderma	0.000449	0.000572	CcSEcCtD
Formoterol—Haematuria—Methotrexate—systemic scleroderma	0.000446	0.000568	CcSEcCtD
Formoterol—Vomiting—Leflunomide—systemic scleroderma	0.000445	0.000567	CcSEcCtD
Formoterol—Hypersensitivity—Lisinopril—systemic scleroderma	0.000443	0.000564	CcSEcCtD
Formoterol—Dizziness—Mycophenolic acid—systemic scleroderma	0.000442	0.000562	CcSEcCtD
Formoterol—Rash—Leflunomide—systemic scleroderma	0.000441	0.000562	CcSEcCtD
Formoterol—Dermatitis—Leflunomide—systemic scleroderma	0.000441	0.000562	CcSEcCtD
Formoterol—Mental disorder—Prednisone—systemic scleroderma	0.000441	0.000561	CcSEcCtD
Formoterol—Nausea—Azathioprine—systemic scleroderma	0.00044	0.000561	CcSEcCtD
Formoterol—Headache—Leflunomide—systemic scleroderma	0.000439	0.000559	CcSEcCtD
Formoterol—Malnutrition—Prednisone—systemic scleroderma	0.000438	0.000558	CcSEcCtD
Formoterol—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000434	0.000553	CcSEcCtD
Formoterol—Asthenia—Lisinopril—systemic scleroderma	0.000432	0.00055	CcSEcCtD
Formoterol—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000431	0.000549	CcSEcCtD
Formoterol—Pruritus—Lisinopril—systemic scleroderma	0.000426	0.000542	CcSEcCtD
Formoterol—Vomiting—Mycophenolic acid—systemic scleroderma	0.000425	0.000541	CcSEcCtD
Formoterol—Rash—Mycophenolic acid—systemic scleroderma	0.000421	0.000536	CcSEcCtD
Formoterol—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000421	0.000536	CcSEcCtD
Formoterol—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000419	0.000533	CcSEcCtD
Formoterol—Headache—Mycophenolic acid—systemic scleroderma	0.000418	0.000533	CcSEcCtD
Formoterol—Pharyngitis—Methotrexate—systemic scleroderma	0.000417	0.000531	CcSEcCtD
Formoterol—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000417	0.000531	CcSEcCtD
Formoterol—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000417	0.000531	CcSEcCtD
Formoterol—Nausea—Leflunomide—systemic scleroderma	0.000416	0.00053	CcSEcCtD
Formoterol—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000415	0.000529	CcSEcCtD
Formoterol—Urethral disorder—Methotrexate—systemic scleroderma	0.000412	0.000525	CcSEcCtD
Formoterol—Diarrhoea—Lisinopril—systemic scleroderma	0.000412	0.000524	CcSEcCtD
Formoterol—Ill-defined disorder—Prednisone—systemic scleroderma	0.000406	0.000517	CcSEcCtD
Formoterol—Visual impairment—Methotrexate—systemic scleroderma	0.000405	0.000516	CcSEcCtD
Formoterol—Agitation—Prednisone—systemic scleroderma	0.000402	0.000512	CcSEcCtD
Formoterol—Angioedema—Prednisone—systemic scleroderma	0.0004	0.000509	CcSEcCtD
Formoterol—Dizziness—Lisinopril—systemic scleroderma	0.000398	0.000507	CcSEcCtD
Formoterol—Nausea—Mycophenolic acid—systemic scleroderma	0.000397	0.000505	CcSEcCtD
Formoterol—Malaise—Prednisone—systemic scleroderma	0.000395	0.000503	CcSEcCtD
Formoterol—Cardiac disorder—Methotrexate—systemic scleroderma	0.00039	0.000497	CcSEcCtD
Formoterol—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000388	0.000495	CcSEcCtD
Formoterol—Vomiting—Lisinopril—systemic scleroderma	0.000382	0.000487	CcSEcCtD
Formoterol—Immune system disorder—Methotrexate—systemic scleroderma	0.00038	0.000483	CcSEcCtD
Formoterol—Rash—Lisinopril—systemic scleroderma	0.000379	0.000483	CcSEcCtD
Formoterol—Dermatitis—Lisinopril—systemic scleroderma	0.000379	0.000483	CcSEcCtD
Formoterol—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000379	0.000482	CcSEcCtD
Formoterol—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000378	0.000482	CcSEcCtD
Formoterol—Hypertension—Prednisone—systemic scleroderma	0.000378	0.000481	CcSEcCtD
Formoterol—Headache—Lisinopril—systemic scleroderma	0.000377	0.00048	CcSEcCtD
Formoterol—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000373	0.000475	CcSEcCtD
Formoterol—Myalgia—Prednisone—systemic scleroderma	0.000373	0.000475	CcSEcCtD
Formoterol—Arthralgia—Prednisone—systemic scleroderma	0.000373	0.000475	CcSEcCtD
Formoterol—Anxiety—Prednisone—systemic scleroderma	0.000371	0.000473	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.00037	0.000471	CcSEcCtD
Formoterol—Discomfort—Prednisone—systemic scleroderma	0.000368	0.000469	CcSEcCtD
Formoterol—Mental disorder—Methotrexate—systemic scleroderma	0.000368	0.000469	CcSEcCtD
Formoterol—Malnutrition—Methotrexate—systemic scleroderma	0.000366	0.000466	CcSEcCtD
Formoterol—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000361	0.000459	CcSEcCtD
Formoterol—Dysgeusia—Methotrexate—systemic scleroderma	0.000358	0.000456	CcSEcCtD
Formoterol—Nausea—Lisinopril—systemic scleroderma	0.000357	0.000455	CcSEcCtD
Formoterol—Oedema—Prednisone—systemic scleroderma	0.000357	0.000455	CcSEcCtD
Formoterol—Anaphylactic shock—Prednisone—systemic scleroderma	0.000357	0.000455	CcSEcCtD
Formoterol—Infection—Prednisone—systemic scleroderma	0.000355	0.000452	CcSEcCtD
Formoterol—Back pain—Methotrexate—systemic scleroderma	0.000354	0.000451	CcSEcCtD
Formoterol—Nervous system disorder—Prednisone—systemic scleroderma	0.00035	0.000446	CcSEcCtD
Formoterol—Tachycardia—Prednisone—systemic scleroderma	0.000349	0.000444	CcSEcCtD
Formoterol—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000348	0.000444	CcSEcCtD
Formoterol—Skin disorder—Prednisone—systemic scleroderma	0.000347	0.000442	CcSEcCtD
Formoterol—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000339	0.000432	CcSEcCtD
Formoterol—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000335	0.000427	CcSEcCtD
Formoterol—Rash—Mycophenolate mofetil—systemic scleroderma	0.000332	0.000423	CcSEcCtD
Formoterol—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000332	0.000423	CcSEcCtD
Formoterol—Headache—Mycophenolate mofetil—systemic scleroderma	0.00033	0.000421	CcSEcCtD
Formoterol—Malaise—Methotrexate—systemic scleroderma	0.00033	0.00042	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000325	0.000415	CcSEcCtD
Formoterol—Insomnia—Prednisone—systemic scleroderma	0.000323	0.000412	CcSEcCtD
Formoterol—Cough—Methotrexate—systemic scleroderma	0.000319	0.000407	CcSEcCtD
Formoterol—Dyspepsia—Prednisone—systemic scleroderma	0.000314	0.000401	CcSEcCtD
Formoterol—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000313	0.000399	CcSEcCtD
Formoterol—Chest pain—Methotrexate—systemic scleroderma	0.000311	0.000397	CcSEcCtD
Formoterol—Arthralgia—Methotrexate—systemic scleroderma	0.000311	0.000397	CcSEcCtD
Formoterol—Myalgia—Methotrexate—systemic scleroderma	0.000311	0.000397	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000309	0.000394	CcSEcCtD
Formoterol—Fatigue—Prednisone—systemic scleroderma	0.000308	0.000392	CcSEcCtD
Formoterol—Discomfort—Methotrexate—systemic scleroderma	0.000308	0.000392	CcSEcCtD
Formoterol—Constipation—Prednisone—systemic scleroderma	0.000305	0.000389	CcSEcCtD
Formoterol—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000299	0.00038	CcSEcCtD
Formoterol—Infection—Methotrexate—systemic scleroderma	0.000297	0.000378	CcSEcCtD
Formoterol—Feeling abnormal—Prednisone—systemic scleroderma	0.000294	0.000375	CcSEcCtD
Formoterol—Nervous system disorder—Methotrexate—systemic scleroderma	0.000293	0.000373	CcSEcCtD
Formoterol—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000292	0.000372	CcSEcCtD
Formoterol—Skin disorder—Methotrexate—systemic scleroderma	0.00029	0.000369	CcSEcCtD
Formoterol—Urticaria—Prednisone—systemic scleroderma	0.000284	0.000361	CcSEcCtD
Formoterol—Abdominal pain—Prednisone—systemic scleroderma	0.000282	0.00036	CcSEcCtD
Formoterol—Body temperature increased—Prednisone—systemic scleroderma	0.000282	0.00036	CcSEcCtD
Formoterol—Hypotension—Methotrexate—systemic scleroderma	0.000279	0.000355	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000272	0.000346	CcSEcCtD
Formoterol—Insomnia—Methotrexate—systemic scleroderma	0.00027	0.000344	CcSEcCtD
Formoterol—Dyspnoea—Methotrexate—systemic scleroderma	0.000266	0.000339	CcSEcCtD
Formoterol—Somnolence—Methotrexate—systemic scleroderma	0.000265	0.000338	CcSEcCtD
Formoterol—Hypersensitivity—Prednisone—systemic scleroderma	0.000263	0.000335	CcSEcCtD
Formoterol—Dyspepsia—Methotrexate—systemic scleroderma	0.000263	0.000335	CcSEcCtD
Formoterol—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000258	0.000328	CcSEcCtD
Formoterol—Fatigue—Methotrexate—systemic scleroderma	0.000257	0.000328	CcSEcCtD
Formoterol—Asthenia—Prednisone—systemic scleroderma	0.000256	0.000326	CcSEcCtD
Formoterol—Pain—Methotrexate—systemic scleroderma	0.000255	0.000325	CcSEcCtD
Formoterol—Pruritus—Prednisone—systemic scleroderma	0.000253	0.000322	CcSEcCtD
Formoterol—Feeling abnormal—Methotrexate—systemic scleroderma	0.000246	0.000313	CcSEcCtD
Formoterol—Diarrhoea—Prednisone—systemic scleroderma	0.000244	0.000311	CcSEcCtD
Formoterol—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000244	0.000311	CcSEcCtD
Formoterol—Urticaria—Methotrexate—systemic scleroderma	0.000237	0.000302	CcSEcCtD
Formoterol—Dizziness—Prednisone—systemic scleroderma	0.000236	0.000301	CcSEcCtD
Formoterol—Abdominal pain—Methotrexate—systemic scleroderma	0.000236	0.000301	CcSEcCtD
Formoterol—Body temperature increased—Methotrexate—systemic scleroderma	0.000236	0.000301	CcSEcCtD
Formoterol—Vomiting—Prednisone—systemic scleroderma	0.000227	0.000289	CcSEcCtD
Formoterol—Rash—Prednisone—systemic scleroderma	0.000225	0.000287	CcSEcCtD
Formoterol—Dermatitis—Prednisone—systemic scleroderma	0.000225	0.000287	CcSEcCtD
Formoterol—Headache—Prednisone—systemic scleroderma	0.000224	0.000285	CcSEcCtD
Formoterol—Hypersensitivity—Methotrexate—systemic scleroderma	0.00022	0.00028	CcSEcCtD
Formoterol—Asthenia—Methotrexate—systemic scleroderma	0.000214	0.000273	CcSEcCtD
Formoterol—Nausea—Prednisone—systemic scleroderma	0.000212	0.00027	CcSEcCtD
Formoterol—Pruritus—Methotrexate—systemic scleroderma	0.000211	0.000269	CcSEcCtD
Formoterol—Diarrhoea—Methotrexate—systemic scleroderma	0.000204	0.00026	CcSEcCtD
Formoterol—Dizziness—Methotrexate—systemic scleroderma	0.000197	0.000251	CcSEcCtD
Formoterol—Vomiting—Methotrexate—systemic scleroderma	0.00019	0.000242	CcSEcCtD
Formoterol—Rash—Methotrexate—systemic scleroderma	0.000188	0.00024	CcSEcCtD
Formoterol—Dermatitis—Methotrexate—systemic scleroderma	0.000188	0.00024	CcSEcCtD
Formoterol—Headache—Methotrexate—systemic scleroderma	0.000187	0.000238	CcSEcCtD
Formoterol—Nausea—Methotrexate—systemic scleroderma	0.000177	0.000226	CcSEcCtD
Formoterol—ADRB1—connective tissue—systemic scleroderma	0.000154	0.0711	CbGeAlD
Formoterol—CYP2A6—lung—systemic scleroderma	0.000116	0.0534	CbGeAlD
Formoterol—ADRB1—lung—systemic scleroderma	9.29e-05	0.0429	CbGeAlD
Formoterol—CYP2C19—digestive system—systemic scleroderma	8.91e-05	0.0411	CbGeAlD
Formoterol—CYP2C9—digestive system—systemic scleroderma	6.91e-05	0.0319	CbGeAlD
Formoterol—CYP2D6—digestive system—systemic scleroderma	5.18e-05	0.0239	CbGeAlD
